Abstract
BackgroundIndacaterol is a long-acting inhaled β2-agonist (LABA) for the treatment of chronic obstructive pulmonary disease (COPD). In previous studies, indacaterol provided 24 h bronchodilation on once-daily dosing with a fast...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have